News
Biohackers convene in Honduras for unregulated gene therapy trials, including Minicircle's
Company Context
- Company Value
- $15M
- Market
- Biotech
- Stage
- Seed
Key Highlight
Minicircle is pioneering a new approach to gene therapy that is non-viral and non-heritable, making it a potentially safer and more accessible option for consumers.
More from Minicircle
More Biotech News
- ColossalColossal Biosciences Reawakens the Dire WolfMar 2026
- ColossalColossal Foundation Doubles Funding to $100MJan 2026
- ColossalColossal Foundation raised $50 millionDec 2025
- AetherRaised $15M to reindustrialize America with AI-designed proteinsDec 2025
- Latus BioAnnounced IND Clearance of LTS-101 for CLN2 DiseaseDec 2025